Skip to main content
. 2020 Mar 25;11:431. doi: 10.3389/fimmu.2020.00431

Figure 3.

Figure 3

Antibodies and protective efficacy after vaccination with αMHCII-H1stem and MIP1α-H1stem. BALB/c mice (n = 10 mice/group) were DNA-immunized twice on days 0 and 29, as indicated by arrows. (A) Sera were analyzed for development of total IgG responses against recombinant HA from PR8 and A/Hong Kong/483/97 (H5N1) and IgG1/IgG2a against HA from PR8. Values given are mean ± SEM. *p < 0.05 as compared to NaCl (two-way ANOVA and Bonferroni post-test). (B) 4 weeks after the final vaccination, mice were challenged with a 5 × LD50 dose of influenza PR8 and monitored for weight loss.